FindTrial
Sign In

A medical records based study for the safety evaluation of COVID-19 vaccine in patients with epilepsy

Safety evaluation of COVID-19 vaccine in patients with epilepsy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047875
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-06-27
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

Case series:COVID-19 vaccine

Sponsors

Shandong University Qilu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with epilepsy according to the criteria proposed by the International Anti-Epilepsy Union in 2017; 2.Aged 18 to 65 years; 3.Patients and their family members gave informed consent to participate in this study voluntarily.

Exclusion criteria

Exclusion criteria: 1. Failure to administer the COVID-19 vaccine as prescribed; 2. Can not cooperate with the completion of the participation questionnaire; 3. Lost to follow-up or the patient withdraws from the study voluntarily during the follow-up.

Design outcomes

Primary

MeasureTime frame
Vaccination will;Reasons for being willing to vaccinate;Reasons for not inoculating;Non-inoculation effect;inoculation rate;—

Countries

China

Contacts

Public ContactLiu Xuewu

Shandong University Qilu Hospital

snlxw1966@163.com+86 18560085520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026